The life and times of the estrogen receptors:an interim report

References

• Revelli A, Massobrio M, Tesarik J. Non genomic action of steroid hormones in reproductive tissues. Endocr Rev 1998:19:3–17
   Google Scholar
• Collins P, Webb C. Estrogens hits the surface. Nature Med 1999;5:1130–1
   PubMed Web of Science ®Google Scholar
• McEwen BS. The molecular and neuroanatomi-cal basis for estrogen effects in the central nervous system. J Clin Endocrinol Metab 1999;84: 1790–7
   PubMed Web of Science ®Google Scholar
• McEwen BS, Alves SE. Estrogen action in the central nervous system. Endocr Rev 1999;20: 279–307
   PubMed Web of Science ®Google Scholar
• Jensen E, Jacobson H. Basic guide to the mecha-nism of oestrogen action. Recent Prog Horm Res 1962;18:387–408
   Google Scholar
• Green S, Walter P, Kumar V, et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature (London) 1986;320:134–9
   PubMed Web of Science ®Google Scholar
• Greene GL, Gilna P, Waterfield M, Baker A, Hort Y, Shine J. Sequence and expression of human estrogen receptor complementary DNA. Science 1986;231:1150–4
   PubMed Web of Science ®Google Scholar
• Leygue ER, Watson PH, Murphy LC. Estrogen receptor variants in normal human mammary tissue. J Natl Cancer Inst 1996;88:284–90
   Google Scholar
• Murphy LC, Dotslaw H, Leygue E, et al. Estrogen receptors variants and mutations. J Steroid Biochem Mol Biol 1997;62;363–72
   PubMed Web of Science ®Google Scholar
• Tsai MJ, O'Malley BW. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Ann Rev Biochem 1994;63:451–86
   PubMed Web of Science ®Google Scholar
• KatzenellenbogenJA,O'MalleyBW,Katzenellenbogen BS. Tripartite steroid hormone receptor pharmacology: interaction with multiple effector sites as a basis for the cell- and promoter-specific action of these hormones. Mol Endocrinol 1996;10:119–31
   PubMed Web of Science ®Google Scholar
• Kuipper GG, Enmark E, Peto-Huikko M, Nilsson S, Gustafson JA. Cloning of a novel receptor expressed in rat prostate and ovary. Proc Natl Acad Sci USA 1996;93;5925–30
   PubMedGoogle Scholar
• Gustafsson JA. Estrogen receptor [3 — a new dimension in estrogen mechanism of action. Review. J Endocrinol 1999;163:379–83
   PubMed Web of Science ®Google Scholar
• Pike ACW, Brzozowski AM, Walton J, et al. Structural insight into the mode of action of a pure antiestrogen. Structure 2001;9:145–53
   PubMed Web of Science ®Google Scholar
• Lees JA, Fawell SE, Parker MG. Identification of two transactivation domains in the mouse estro-gen receptor. Nucleic Acid Res 1989;17:5477–88
   Google Scholar
• Kato S, Endoh H, Masuhiro Y, et al . Activation of the estrogen receptor through phosphoryilation by mitogen-activated protein-kinase. Science 1995;270:1491–4
   Google Scholar
• Tzukerman WT, Esty A, Sanrtisomere D, et al. Human estrogen-receptor transactional capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 1994;8:21–30
   PubMed Web of Science ®Google Scholar
• Webster NJG, Green S, Jin JR, Chambon P. The hormone-binding domains of the oestrogen and glucocorticoid receptor contain an inducible transcription activation function. Cell 1988;54: 199–207
   PubMed Web of Science ®Google Scholar
• Kraus WL, McInerney EM, Katzenellenbogen BS. Ligand-dependent, transcriptionally produc-tive association of the amino- and carboxyl-terminal region of a steroid nuclear receptor. Proc Natl Acad Sci USA 1995;92:12314–18
   Google Scholar
• Zilliacus J, Carlstedt-Duke J, Gustafsson JA, Wright APH. Evolution of distinct DNA-binding specificities within the nuclear receptor family of transcription factors. Proc Natl Acad Sci USA 1994;91 4175–9
   PubMed Web of Science ®Google Scholar
• Enmark E, Pelto-Huikko M, Grandien K, et al. Human estrogen receptor 0-gene structure, chromosomal localisation, and expression pattern. J Clin Endocrinol Metab 1997;82: 4258–65
   PubMed Web of Science ®Google Scholar
• Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L. Nuclear receptor co-activators and corepressors. Mol Endocrinol 1996;10:1167–77
   PubMed Web of Science ®Google Scholar
• McKenna NJ, Lanza RB, O'Malley BW. Nuclear receptor coagulator: cellular and molecular biology. Endocr Rev. 1999;20:321–44
   Google Scholar
• Cavailles V, Dauvois S, L'Horset F, et al. Nuclear factor RIP 140 modulates transcriptional activa-tion by the estrogen receptor. EMBO J 1995;14: 3741–51
   Google Scholar
• Voegel JJ, Heine MJS, Zechel C, Chambon P, Gronemeyer H. TIF, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMB 0 J 1996;15: 3667–75
   Google Scholar
• sadate SA, Tsai SY, Tsai M-J, O'Malley BW. Sequence and characterisation of a coactivator for the steroid hormone receptor superfamily. Science 1995;270:1354–57
   Google Scholar
• McInerney EM, Weiss KE, Sun J, Mosselman S, Katzenellenbogen BS. Transcription activation by the human estrogen receptor subtype 0 (E120) studied with ER0 and ERa receptor chimeras. Endocrinology 1998;139: 4513–22
   Google Scholar
• Bowler J, Lilley TJ, Pittam JD, Wakeling AE. Novel steroidal pure antiestrogens. Steroids 1989;54:71–99
   PubMedGoogle Scholar
• McDonnell DP, Clemm DL, Hermann T, Goldam ME, Pike JW. Analysis of estrogen recep-tor function in vitro reveals three distinct classes of antiestrogens . Mol Endocrinol 1995;9:659–99
   Google Scholar
• Danielian PS, White R, Lees JA, Parker MG. Identification of conserved region required for hormone dependent transcriptional activation by steroid hormone binding receptors. EMB 0 J 1992;11:1025–33
   PubMed Web of Science ®Google Scholar
• Darimont BD, Wagner RL, Apriletti JW, et al. Structure and specificity of nuclear receptor—coactivator interactions. Genes Dev 1998;12: 3343–56
   PubMed Web of Science ®Google Scholar
• Brzowski AM, Pike ACW, Dauter Z, et al. Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 1997;389:753–8
   PubMed Web of Science ®Google Scholar
• Paech K, Webb P, Kuipper GGJM, et al. Differen-tial ligand activation of oestrogen receptor ERa and 0 at AP1 sites. Science 1997;277:1508–10
   PubMed Web of Science ®Google Scholar
• Krege JH, Hodgin JB, Course JF, et al. Genera-tion and reproductive phenotypes of mice lacking estrogen receptor beta. Proc Natl Acad Sci USA 1998;95:15677–82
   PubMed Web of Science ®Google Scholar
• Course JF, Curtis Hewitt S, Bunch DO, et al. Postnatal sex reversal of the ovary in mice lacking estrogen receptor afl. Science 1999;286:2328–31
   PubMed Web of Science ®Google Scholar
• Course JF, Korak KS. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr Rev 1999;20:358–417
   PubMed Web of Science ®Google Scholar
• Course JF, Lindzey J, Grandien K, Gustafsson JA, Korak KS. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ER alpha) and estrogen receptor beta (ER-beta) messenger ribonucleic acid in the wild-type and ER alpha-knockout mouse. Endocrinology 1997;138: 4613–21
   Google Scholar
• Brandenberger AW, Tee MK, Jaffe RB. Estrogen receptor-a (ERa) and estrogen receptor-0 (E120) mRNAs in normal ovaries, ovarian serous cyst-adenocarcinoma and ovarian cancer cell lines: down regulation of ER0 in neoplastic tissues. J Clin Endocrinol Metab 1998;83: 1025–8
   Google Scholar
• Misaao R, Nakanishi Y, Sun WS, et al. Expres-sion of oestrogen recepror-a and — ER-I3 mRNA in corpus luteum of human subjects. Mol Hum Reprod 1999;5:17–21
   PubMedGoogle Scholar
• Buchanan DL, Setiawan T, Lubahn DB, et al. Tissue compartment-specific estrogen receptor-a participation in the mouse uterine epitheleial secretory response. Endocrinology 1999;140: 484–91
   PubMed Web of Science ®Google Scholar
• Pelletier G, El-Alfy M. Immunocytochemical localisation of estrogen receptors a and 0 in the human reproductive organs. J Clin Endocrinol Metab 2000;85:4835–40
   PubMed Web of Science ®Google Scholar
• Speirs V, Adams IP, Walton DS, Atkins SL. Identification of wild-type and exon 5 deletion variants of estrogen receptor 0 in normal human mammary gland. J Clin Endocrinol Metab 2000;85:1601–5
   PubMed Web of Science ®Google Scholar
• Bocchinfuso WP, Korak KS. Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia 1997;2:323–34
   PubMed Web of Science ®Google Scholar
• Lawson JS, Field AS, Champion S, Tran D, Ishikua H, Tricopulos D. Low oestrogen receptor a expression in normal breast tissue underlies low breast cancer incidence in Japan. Lancet 1999;354:1787–8
   PubMed Web of Science ®Google Scholar
• Bland R. Steroid hormone receptor expression and action on bone. Clin Sci 2000;98:217–40
   PubMed Web of Science ®Google Scholar
• Komm B, Henderson R, Bodine P, Green J, Lian J, Stein G. The estrogen receptor is developmentally up-regulated during osteoblast differentiation. J Bone Miner Res 1996;11:M308
   Web of Science ®Google Scholar
• Bodine PVN, Henderson RRA, Green J, et al. Estrogen receptor-a is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression. Endocrinology 1998;139;2048–57
   PubMed Web of Science ®Google Scholar
• Arts J, Kuipper GGJM, Jansen JMMF, et al. Differential expression of estrogen receptor a and 0 mRNA during differentiation of human osteo-blast SV-HFO cells. Endocrinology 1997;138; 5067–70
   PubMed Web of Science ®Google Scholar
• Hoyland JA, Mee AP, Baird P, Braidman IP, Mawer EB, Freemont AJ. Demonstration of estrogen receptor mRNA in bone using in situ reverse-transcriptase polymerase chain reaction. Bone 1997;20:87–92
   PubMed Web of Science ®Google Scholar
• Osterlund MK, Keller E, Hurd YL. The human forebrain has discrete estrogen receptor alpha messenger RNA expression: high levels in the amygdaloid complex. Neuroscience 2000;95: 333–42
   Google Scholar
• Lindner V, Kim S, Karas R, et al. Increased expression of estrogen receptor-beta mRNA inmale blood vessels after vascular injury. Circ Res 1998;83:224–9
   PubMed Web of Science ®Google Scholar
• Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994; 89:1943–50
   Google Scholar
• Register TC, Adams MR. Coronary artery and cultured aortic smooth muscle cells express mRNA for both the classical estrogen receptor and the newly described estrogen receptor beta. J Steroid Biochem Mol Biol 1998;64:187–91
   PubMed Web of Science ®Google Scholar
• Gulshan S, McCruden AB, Stimson WH. Oestro-gen receptors in macrophages. Scand J Immunol 1990;31:691–7
   PubMed Web of Science ®Google Scholar
• Suenaga R, Evans MJ, Mitamura K, Rider V, Abdou NI. Peripheral blood T cells andmonocytes and B cell lines derived from patients with lupus express estrogen receptor transcript similar to those of normal cell. J Rheumatol 1998;25:1305–12
   Google Scholar
• Hodgin JB, Krege JH, Reddik RL, Korak KS, Smithies 0, Maeda N. Estrogen receptor a is a major mediator of 170-estradiol's athero-protective effects on lesion size in Apo E —0— mice. J Clin Invest 2001;107: 333–40
   Google Scholar
• Machela S, Savolainen H, Aavik E, et al. Differen-tiation between vasculoprotective and utero-trophic effects of ligands with different binding affinities to estrogen receptor a and I. Proc Natl Acad Sci USA 1999;96:7077–82
   PubMed Web of Science ®Google Scholar